159 related articles for article (PubMed ID: 23001481)
1. Regulation of hepatitis C virus replication and gene expression by the MAPK-ERK pathway.
Pei R; Zhang X; Xu S; Meng Z; Roggendorf M; Lu M; Chen X
Virol Sin; 2012 Oct; 27(5):278-85. PubMed ID: 23001481
[TBL] [Abstract][Full Text] [Related]
2. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
[TBL] [Abstract][Full Text] [Related]
3. Induced oxidative stress and activated expression of manganese superoxide dismutase during hepatitis C virus replication: role of JNK, p38 MAPK and AP-1.
Qadri I; Iwahashi M; Capasso JM; Hopken MW; Flores S; Schaack J; Simon FR
Biochem J; 2004 Mar; 378(Pt 3):919-28. PubMed ID: 14670077
[TBL] [Abstract][Full Text] [Related]
4. Involvement of ERK pathway in interferon alpha-mediated antiviral activity against hepatitis C virus.
Zhao LJ; Wang W; Wang WB; Ren H; Qi ZT
Cytokine; 2015 Mar; 72(1):17-24. PubMed ID: 25544181
[TBL] [Abstract][Full Text] [Related]
5. Bile acids promote HCV replication through the EGFR/ERK pathway in replicon-harboring cells.
Patton JB; George D; Chang KO
Intervirology; 2011; 54(6):339-48. PubMed ID: 21293096
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic link between the anti-HCV effect of interferon gamma and control of viral replication by a Ras-MAPK signaling cascade.
Huang Y; Chen XC; Konduri M; Fomina N; Lu J; Jin L; Kolykhalov A; Tan SL
Hepatology; 2006 Jan; 43(1):81-90. PubMed ID: 16374867
[TBL] [Abstract][Full Text] [Related]
7. Expression of an IRF-3 fusion protein and mouse estrogen receptor, inhibits hepatitis C viral replication in RIG-I-deficient Huh 7.5 cells.
Yao L; Yan X; Dong H; Nelson DR; Liu C; Li X
Virol J; 2011 Sep; 8():445. PubMed ID: 21936899
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus inhibits intracellular interferon alpha expression in human hepatic cell lines.
Zhang T; Lin RT; Li Y; Douglas SD; Maxcey C; Ho C; Lai JP; Wang YJ; Wan Q; Ho WZ
Hepatology; 2005 Oct; 42(4):819-27. PubMed ID: 16175599
[TBL] [Abstract][Full Text] [Related]
9. Contrasting roles of mitogen-activated protein kinases in cellular entry and replication of hepatitis C virus: MKNK1 facilitates cell entry.
Kim S; Ishida H; Yamane D; Yi M; Swinney DC; Foung S; Lemon SM
J Virol; 2013 Apr; 87(8):4214-24. PubMed ID: 23365451
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of hepatitis C virus replication and production by inhibition of MEK/ERK signaling.
Ndjomou J; Park IW; Liu Y; Mayo LD; He JJ
PLoS One; 2009 Oct; 4(10):e7498. PubMed ID: 19834602
[TBL] [Abstract][Full Text] [Related]
11. Ribavirin enhances the action of interferon-α against hepatitis C virus by promoting the p53 activity through the ERK1/2 pathway.
Liu WL; Yang HC; Su WC; Wang CC; Chen HL; Wang HY; Huang WH; Chen DS; Lai MY
PLoS One; 2012; 7(9):e43824. PubMed ID: 22962590
[TBL] [Abstract][Full Text] [Related]
12. Celastrol inhibits hepatitis C virus replication by upregulating heme oxygenase-1 via the JNK MAPK/Nrf2 pathway in human hepatoma cells.
Tseng CK; Hsu SP; Lin CK; Wu YH; Lee JC; Young KC
Antiviral Res; 2017 Oct; 146():191-200. PubMed ID: 28935193
[TBL] [Abstract][Full Text] [Related]
13. Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatment.
Chang JH; Kato N; Muroyama R; Taniguchi H; Guleng B; Dharel N; Shao RX; Tateishi K; Jazag A; Kawabe T; Omata M
Liver Int; 2010 Feb; 30(2):311-8. PubMed ID: 19840259
[TBL] [Abstract][Full Text] [Related]
14. CD40 inhibits replication of hepatitis C virus in primary human hepatocytes by c-Jun N terminal kinase activation independent from the interferon pathway.
Rau SJ; Hildt E; Himmelsbach K; Thimme R; Wakita T; Blum HE; Fischer R
Hepatology; 2013 Jan; 57(1):23-36. PubMed ID: 22814930
[TBL] [Abstract][Full Text] [Related]
15. Interference with ERK and STAT signaling pathways and inhibition of hepatitis C virus replication by ribavirin.
Zhao LJ; Wang W; Liu Y; Ren H; Qi ZT
Antiviral Res; 2012 Nov; 96(2):260-8. PubMed ID: 22985631
[TBL] [Abstract][Full Text] [Related]
16. Acetylsalicylic acid inhibits hepatitis C virus RNA and protein expression through cyclooxygenase 2 signaling pathways.
Trujillo-Murillo K; Rincón-Sánchez AR; Martínez-Rodríguez H; Bosques-Padilla F; Ramos-Jiménez J; Barrera-Saldaña HA; Rojkind M; Rivas-Estilla AM
Hepatology; 2008 May; 47(5):1462-72. PubMed ID: 18393288
[TBL] [Abstract][Full Text] [Related]
17. ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.
Abe H; Imamura M; Hiraga N; Tsuge M; Mitsui F; Kawaoka T; Takahashi S; Ochi H; Maekawa T; Hayes CN; Tateno C; Yoshizato K; Murakami S; Yamashita N; Matsuhira T; Asai K; Chayama K
J Hepatol; 2011 Jul; 55(1):11-8. PubMed ID: 21145867
[TBL] [Abstract][Full Text] [Related]
18. DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.
Grünvogel O; Esser-Nobis K; Reustle A; Schult P; Müller B; Metz P; Trippler M; Windisch MP; Frese M; Binder M; Fackler O; Bartenschlager R; Ruggieri A; Lohmann V
J Virol; 2015 Oct; 89(20):10548-68. PubMed ID: 26269178
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus RNA replication is regulated by Ras-Erk signalling.
Gretton S; Hughes M; Harris M
J Gen Virol; 2010 Mar; 91(Pt 3):671-80. PubMed ID: 19889932
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporin A inhibits hepatitis C virus replication and restores interferon-alpha expression in hepatocytes.
Liu JP; Ye L; Wang X; Li JL; Ho WZ
Transpl Infect Dis; 2011 Feb; 13(1):24-32. PubMed ID: 21040279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
